Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years PfizerCovid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says CNNHow Moderna Stock Can Double From Here Motley FoolCovid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says The New York TimesCovid vaccine is safe for kids aged 5-11, Pfizer says CNNView Full Coverage on Google News